Income Tax Expense (Benefit) of Lexaria Bioscience Corp. from 31 Aug 2016 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Lexaria Bioscience Corp. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Aug 2016 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Income Tax Expense (Benefit) for the quarter ending 30 Nov 2025 was $1,791.
  • Lexaria Bioscience Corp. annual Income Tax Expense (Benefit) for 2022 was $0, a 100% decline from 2021.
  • Lexaria Bioscience Corp. annual Income Tax Expense (Benefit) for 2021 was $6,093, a 163% increase from 2020.
  • Lexaria Bioscience Corp. annual Income Tax Expense (Benefit) for 2020 was $2,319, a 87% decline from 2019.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Lexaria Bioscience Corp. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,791 +$1,791 01 Sep 2025 30 Nov 2025 10-Q 13 Jan 2026 2026 Q1
Q4 2024 $0 01 Sep 2024 30 Nov 2024 10-Q 13 Jan 2026 2026 Q1

Lexaria Bioscience Corp. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $0 -$6,093 -100% 01 Sep 2021 31 Aug 2022 10-K 28 Nov 2022 2022 FY
2021 $6,093 +$3,774 +163% 01 Sep 2020 31 Aug 2021 10-K 28 Nov 2022 2022 FY
2020 $2,319 -$15,345 -87% 01 Sep 2019 31 Aug 2020 10-K 29 Nov 2021 2021 FY
2019 $17,664 +$17,664 01 Sep 2018 31 Aug 2019 10-K 15 Oct 2020 2020 FY
2018 $0 $0 01 Sep 2017 31 Aug 2018 10-K 14 Nov 2019 2019 FY
2017 $0 $0 01 Sep 2016 31 Aug 2017 10-K 14 Nov 2018 2018 FY
2016 $0 01 Sep 2015 31 Aug 2016 10-K 14 Nov 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.